Ovid Therapeutics Inc

General ticker "OVID" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $76.7M

Ovid Therapeutics Inc does not follow the US Stock Market performance with the rate: -36.5%.

Estimated limits based on current volatility of 3.5%: low 0.97$, high 1.04$

Factors to consider:

  • Current price 67.1% below estimated low
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [2.88$, 5.96$]
  • 2024-12-30 to 2025-12-30 estimated range: [2.84$, 5.94$]

Financial Metrics affecting the OVID estimates:

  • Negative: Non-GAAP EPS, $ of -0.75 <= 0.10
  • Negative: Operating profit margin, % of -99.34 <= 1.03
  • Negative: Operating cash flow per share per price, % of -16.35 <= 2.35
  • Negative: negative Net income
  • Positive: Industry inventory ratio change (median), % of 0 <= 0

Similar symbols

Short-term OVID quotes

Long-term OVID plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $208.38MM $1.50MM $0.39MM
Operating Expenses $84.17MM $57.05MM $59.67MM
Operating Income $124.21MM $-55.55MM $-59.28MM
Non-Operating Income $-0.05MM $1.38MM $6.94MM
R&D Expense $46.94MM $24.62MM $28.59MM
Income(Loss) $124.16MM $-54.17MM $-52.34MM
Taxes $1.33MM $0.00MM $0.00MM
Profit(Loss) $122.83MM $-54.17MM $-52.34MM
Stockholders Equity $179.75MM $132.27MM $87.80MM
Assets $194.54MM $155.27MM $144.03MM
Operating Cash Flow $118.61MM $-55.23MM $-45.78MM
Capital expenditure $0.19MM $1.42MM $0.14MM
Investing Cash Flow $-1.82MM $-87.88MM $-2.58MM
Financing Cash Flow $0.90MM $0.18MM $30.54MM
Earnings Per Share* $1.78 $-0.73 $-0.74

* EPS are Split Adjusted, recent splits may be reflected with a delay.